This is supported by our recent observation that a variant in the telomerase gene, hTERT, increases cancer risk in young LS patients (<45 years of age), as it is associated with shortened telomeres in cancer-affected MMR gene mutation carriers [11]. The gene discussed is MRC1; the disease is Leigh syndrome.